Spanish Red Biotech Pipeline

CIBER

GENETICALLY MODIFIED MSCs overexpressing CXCR4-IL10 AS ALTERNATIVE TREATMENT FOR GRAFT versus HOST DISEASE

Type: Gene / Cell Therapy
Therapeutic area:
Indication: GRAFT versus HOST DISEASE
Phase: 2Regulatory Preclinical, 1Non Regulatory Preclinical